Premium
Alto Neuroscience Inc (ANRO)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Alpha Wave Global, LP | Institution | 3 707 757 | 10,57% | US$ 102,48M | 2026-03-31 |
| Commodore Capital LP | Institution | 2 723 196 | 7,76% | US$ 75,27M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 2 064 075 | 5,88% | US$ 57,05M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 2 009 893 | 5,73% | US$ 55,55M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 1 989 393 | 5,67% | US$ 54,99M | 2025-10-03 |
| Armistice Capital Master Fund Ltd. | Institution | 1 536 000 | 4,38% | US$ 42,46M | 2025-12-31 |
| Spruce Street Capital LP | Institution | 1 325 210 | 3,78% | US$ 36,63M | 2026-03-31 |
| Point72 Associates, LLC | Institution | 1 240 053 | 3,53% | US$ 34,28M | 2025-03-31 |
| Point72 Asset Management, L.P. | Institution | 1 170 865 | 3,34% | US$ 32,36M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 1 101 874 | 3,14% | US$ 30,46M | 2026-03-31 |
| Vivo Capital, LLC | Institution | 1 035 551 | 2,95% | US$ 28,62M | 2026-03-31 |
| Armistice Capital LLC | Institution | 912 000 | 2,60% | US$ 25,21M | 2026-03-31 |
| Millennium Management LLC | Institution | 821 982 | 2,34% | US$ 22,72M | 2026-03-31 |
| BlackRock, Inc. | Institution | 666 188 | 1,90% | US$ 18,41M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 515 000 | 1,47% | US$ 14,23M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 500 000 | 1,42% | US$ 13,82M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 500 000 | 1,42% | US$ 13,82M | 2026-03-31 |
| VR Management, LLC | Institution | 500 000 | 1,42% | US$ 13,82M | 2026-03-31 |
| Driehaus Capital Management LLC | Institution | 486 726 | 1,39% | US$ 13,45M | 2026-03-31 |
| Jennison Associates LLC | Institution | 386 426 | 1,10% | US$ 10,68M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 385 000 | 1,10% | US$ 10,64M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 371 208 | 1,06% | US$ 10,26M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 238 498 | 0,68% | US$ 6,59M | 2026-03-31 |
| Alkeon Capital Management, LLC | Institution | 227 101 | 0,65% | US$ 6,28M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 216 099 | 0,62% | US$ 5,97M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 209 268 | 0,60% | US$ 5,78M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 199 503 | 0,57% | US$ 5,51M | 2026-03-31 |
| Marshall Wace LLP | Institution | 176 347 | 0,50% | US$ 4,87M | 2026-03-31 |
| AWM Investment Company Inc | Institution | 170 000 | 0,48% | US$ 4,70M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 167 500 | 0,48% | US$ 4,63M | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 139 304 | 0,40% | US$ 3,85M | 2026-03-31 |
| Eversept Partners, L.P. | Institution | 125 168 | 0,36% | US$ 3,46M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 94 022 | 0,27% | US$ 2,60M | 2026-03-31 |
| Saturn V Capital Management LP | Institution | 88 999 | 0,25% | US$ 2,46M | 2026-03-31 |
| Almitas Capital LLC | Institution | 78 520 | 0,22% | US$ 2,17M | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 52 653 | 0,15% | US$ 1,46M | 2026-03-31 |
| TD Asset Management, Inc. | Institution | 43 800 | 0,12% | US$ 1,21M | 2026-03-31 |
| AdvisorShares Investments, LLC | Institution | 41 023 | 0,12% | US$ 1,13M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
